Human Spleen Focus Forming Virus ProViral Integration Oncogene ELISA Kit
Cat# MBS080592-5x96
Size : 5x96-Strip-Wells
Brand : MyBiosource
Spleen Focus Forming Virus Proviral Integration Oncogene (SPI1) ELISA Kit for Human
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS080592MBS080592 is a ready-to-use microwell, strip plate ELISA (enzyme-linked immunosorbent assay) Kit for analyzing the presence of the Spleen Focus Forming Virus ProViral Integration Oncogene (SPI1) ELISA Kit target analytes in biological samples. The… More details
Product Overview
Online Datasheet in PDFProduct Name
Spleen Focus Forming Virus ProViral Integration Oncogene (SPI1), ELISA Kit
Full Product Name
Human Spleen Focus Forming Virus ProViral Integration Oncogene ELISA Kit
Product Gene Name
SPI1 elisa kit
Species Reactivity
Human
Preparation and Storage
Store all reagents at 2-8 degree C
Other Notes
Small volumes of SPI1 elisa kit vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Additional Details
NCBI/Uniprot data below describe general gene information for SPI1. It may not necessarily be applicable to this product.
NCBI Official Full Name
spleen focus forming virus (SFFV) proviral integration oncogene spi1, isoform CRA_c, partial
NCBI Official Synonym Full Names
Spi-1 proto-oncogene
NCBI Official Symbol
SPI1
NCBI Official Synonym Symbols
OF; PU.1; SFPI1; SPI-1; SPI-A
UniProt Protein Name
Transcription factor PU.1
UniProt Synonym Protein Names
31 kDa-transforming protein
Protein Family
GTP-binding nuclear protein
UniProt Gene Name
SPI1
UniProt Entry Name
SPI1_HUMAN
NCBI Protein Information
transcription factor PU.1; 31 kDa transforming protein; 31 kDa-transforming protein; hematopoietic transcription factor PU.1; spleen focus forming virus (SFFV) proviral integration oncogene spi1
NCBI Summary for SPI1
This gene encodes an ETS-domain transcription factor that activates gene expression during myeloid and B-lymphoid cell development. The nuclear protein binds to a purine-rich sequence known as the PU-box found near the promoters of target genes, and regulates their expression in coordination with other transcription factors and cofactors. The protein can also regulate alternative splicing of target genes. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
Show more UniProt Comments for SPI1
PU.1: Binds to the PU-box, a purine-rich DNA sequence (5'- GAGGAA-3') that can act as a lymphoid-specific enhancer. This protein is a transcriptional activator that may be specifically involved in the differentiation or activation of macrophages or B- cells. Also binds RNA and may modulate pre-mRNA splicing. Binds DNA as a monomer. Interacts with CEBPD and NONO. Interacts with RUNX1 and SPIB. Interacts with GFI1; the interaction represses SPI1 transcriptional activity. Highly expressed in both FV-P and FV-A-induced erythro- leukemia cell lines that have undergone rearrangements of the Spi- 1 gene due to the insertion of SFFV. Belongs to the ETS family. 2 isoforms of the human protein are produced by alternative splicing.
Protein type: Oncoprotein; Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 11p11.2
Cellular Component: nuclear chromatin
Molecular Function: RNA polymerase II transcription factor activity, enhancer binding; protein binding; NFAT protein binding; RNA binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; macrophage differentiation; granulocyte differentiation; somatic stem cell maintenance; positive regulation of transcription, DNA-dependent; myeloid dendritic cell differentiation; lymphoid progenitor cell differentiation; negative regulation of transcription from RNA polymerase II promoter; anatomical structure regression; regulation of transcription from RNA polymerase II promoter; regulation of erythrocyte differentiation; lymphocyte differentiation; negative regulation of gene expression, epigenetic; negative regulation of MHC class II biosynthetic process; erythrocyte differentiation; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent
Show more Protein type: Oncoprotein; Transcription factor; DNA-binding
Chromosomal Location of Human Ortholog: 11p11.2
Cellular Component: nuclear chromatin
Molecular Function: RNA polymerase II transcription factor activity, enhancer binding; protein binding; NFAT protein binding; RNA binding; transcription factor activity
Biological Process: transcription from RNA polymerase II promoter; macrophage differentiation; granulocyte differentiation; somatic stem cell maintenance; positive regulation of transcription, DNA-dependent; myeloid dendritic cell differentiation; lymphoid progenitor cell differentiation; negative regulation of transcription from RNA polymerase II promoter; anatomical structure regression; regulation of transcription from RNA polymerase II promoter; regulation of erythrocyte differentiation; lymphocyte differentiation; negative regulation of gene expression, epigenetic; negative regulation of MHC class II biosynthetic process; erythrocyte differentiation; positive regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with SPI1 elisa kit
| Reference Product | PubMed Publications |
|---|---|
| JUN elisa kit | >42 publications with SPI1 and JUN |
| RUNX1 elisa kit | >9 publications with SPI1 and RUNX1 |
| IRF8 elisa kit | >4 publications with SPI1 and IRF8 |
| GATA2 elisa kit | >4 publications with SPI1 and GATA2 |
| IRF4 elisa kit | >3 publications with SPI1 and IRF4 |
| TBP elisa kit | >2 publications with SPI1 and TBP |
| PRTN3 elisa kit | >1 publications with SPI1 and PRTN3 |
| CSF1R elisa kit | >1 publications with SPI1 and CSF1R |
Pathways associated with SPI1 elisa kit
| Products by Pathway | Pathway Diagram |
|---|---|
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| Acute Myeloid Leukemia Pathway antibodies | Acute Myeloid Leukemia Pathway Diagram |
| C-MYB Transcription Factor Network Pathway antibodies | C-MYB Transcription Factor Network Pathway Diagram |
| Epstein-Barr Virus Infection Pathway antibodies | Epstein-Barr Virus Infection Pathway Diagram |
| Epstein-Barr Virus Infection Pathway antibodies | Epstein-Barr Virus Infection Pathway Diagram |
| Glucocorticoid Receptor Regulatory Network Pathway antibodies | Glucocorticoid Receptor Regulatory Network Pathway Diagram |
| HTLV-I Infection Pathway antibodies | HTLV-I Infection Pathway Diagram |
| HTLV-I Infection Pathway antibodies | HTLV-I Infection Pathway Diagram |
| IL-3 Signaling Pathway antibodies | IL-3 Signaling Pathway Diagram |
| IL-4 Signaling Pathway antibodies | IL-4 Signaling Pathway Diagram |
Diseases associated with SPI1 elisa kit
| Disease Name | Pubmed Publications |
|---|---|
| Neoplasms Antibodies | >32 publications with SPI1 and Neoplasms |
| Inflammation Antibodies | >21 publications with SPI1 and Inflammation |
| Leukemia, Myeloid Antibodies | >20 publications with SPI1 and Leukemia, Myeloid |
| Disease Models, Animal Antibodies | >13 publications with SPI1 and Disease Models, Animal |
| Liver Diseases Antibodies | >7 publications with SPI1 and Liver Diseases |
| Neoplasms, Experimental Antibodies | >5 publications with SPI1 and Neoplasms, Experimental |
| Necrosis Antibodies | >5 publications with SPI1 and Necrosis |
| Lung Diseases Antibodies | >5 publications with SPI1 and Lung Diseases |
| Atherosclerosis Antibodies | >4 publications with SPI1 and Atherosclerosis |
| Vascular Diseases Antibodies | >4 publications with SPI1 and Vascular Diseases |
Organs/Tissues associated with SPI1 elisa kit
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Blood Antibodies | >53 publications with SPI1 and Blood |
| Intestine Antibodies | >42 publications with SPI1 and Intestine |
| Spleen Antibodies | >23 publications with SPI1 and Spleen |
| Liver Antibodies | >10 publications with SPI1 and Liver |
| Heart Antibodies | >6 publications with SPI1 and Heart |
| Lymph Node Antibodies | >6 publications with SPI1 and Lymph Node |
| Lymph Antibodies | >5 publications with SPI1 and Lymph |
| Lung Antibodies | >5 publications with SPI1 and Lung |
| Kidney Antibodies | >3 publications with SPI1 and Kidney |
| Placenta Antibodies | >2 publications with SPI1 and Placenta |


